Syncona Limited (SYNC) Ordinary NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
109.00p
111.60p
136.20p
179.40
109.00p
108.40p
101.00p
-39.24%
2.00p (1.87%) Previous:
2.00p
435,320
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
1 week 1W | 1.65% | 1 year 1Y | 15.27% |
---|---|---|---|
1 month 1M | 0.91% | 2 years 2Y | 37.99% |
3 months 3M | 4.48% | 3 years 3Y | 45.85% |
6 months 6M | 9.02% | 5 years 5Y | 52.77% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | FTSE 250 TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | No |
Ongoing charge: | 1.74% |
Dividend yield: | n/a |
Dividend frequency: | Annually |
Total assets: | £1,138m |
Gross gearing: | 0% |
Market capitalisation:Market cap.: | £692m |
Shares in issue: | 634.47 million |
Legal structure | Closed Ended Investment Company |
Domicile: | Guernsey |
ISIN | GG00B8P59C08 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 179.40p |
---|---|
Latest actual NAV: | 179.40p |
Latest actual NAV date: | 30 June 2024 |
Premium/Discount: | -39.24% |
12m average Premium/Discount: | -35.55% |
NAV frequency: | Quarterly |
Security | Weight |
---|---|
Capital Pool | 36.32% |
Spur Therapeutics | 11.79% |
Beacon Therapeutics | 8.61% |
Autolus Therapeutics | 7.95% |
Quell Therapeutics | 7.29% |
Resolution Therapeutics | 4.33% |
Purespring Therapeutics | 3.92% |
Omass Therapeutics | 3.77% |
Anaveon | 3.09% |
Crt Pioneer Fund | 2.84% |
Top 10 sectors currently unavailable.
Country | Weight |
---|---|
United Kingdom | 8.57% |
United States | 0.22% |
Key Dates
Launch date: | 26 October 2012 |
---|---|
Financial year end: | March |
Next AGM: | August 2025 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.